How do you pay?

How to pay the least

Cash price

$680+ for 30 tablets

Pharmacies pay about this for Kerendia; you’d pay more.

  1. Ask your pharmacy for Kerendia’s cash price, and one or two other pharmacies too.
  2. Kerendia’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Bayer US Patient Assistance Foundation. Effective January 1, 2025, the financial eligibility requirement is 300% Federal Poverty Limit (FPL) for most Bayer prescription medications. Or call 1-866-228-7723.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameKerendia
Authorized genericfinerenone
Regular genericfinerenone
What you’d pay
At least$680for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Kerendia?
The original
–
–

Brand nameThe maker’s card

KERENDIA Copay Savings Card

Savings card from Bayer

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on kerendia-us.com 

Or text SAVE to 53736, or call 1-888-537-3634. See the offer on kerendia-us.com

In the maker’s words

“Eligible commercial patients may pay as little as $0 per month for KERENDIA.”

From the maker’s offer on kerendia-us.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Kerendia itself, from the same company, sold without the brand name, and usually for less. For now Kerendia is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

Kerendia is a non-steroidal mineralocorticoid receptor antagonist (nsMRA) indicated to:

  • reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with Type 2 diabetes mellitus (T2DM).
  • reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained eGFR decline and end-stage kidney disease in adults with CKD associated with Type 1 diabetes mellitus (T1DM).
  • reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure with left ventricular ejection fraction (LVEF) ≥ 40%.

Source: the FDA label for Kerendia (Bayer HealthCare Pharmaceuticals Inc.), September 21, 2026. Full label on DailyMed 

Good to know